Mesoblast (MESO) - 2023 Q4 - Annual Report

mesol August 2023 Global Leader in Allogeneic Cellular M« for Inflammatory Diseases Financial Results and Operational Update for the Year Ended June 30, 2023 ASX: MSB; Nasdaq: MESO CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties a results. levels of activity, performance or achievements to differ materially from any future results. Iev ...